BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32900353)

  • 1. Fluorinated-NHC Transition Metal Complexes: Leading Characters as Potential Anticancer Metallodrugs.
    Rufino-Felipe E; Colorado-Peralta R; Reyes-Márquez V; Valdés H; Morales-Morales D
    Anticancer Agents Med Chem; 2021; 21(8):938-948. PubMed ID: 32900353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Heterocyclic carbene metal complexes in medicinal chemistry.
    Oehninger L; Rubbiani R; Ott I
    Dalton Trans; 2013 Mar; 42(10):3269-84. PubMed ID: 23223752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anticancer activity of an air-stable Pd(I)-NHC (NHC = N-heterocyclic carbene) dimer.
    Scattolin T; Bortolamiol E; Palazzolo S; Caligiuri I; Perin T; Canzonieri V; Demitri N; Rizzolio F; Cavallo L; Dereli B; Mane MV; Nolan SP; Visentin F
    Chem Commun (Camb); 2020 Oct; 56(81):12238-12241. PubMed ID: 32926011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coinage Metal N-Heterocyclic Carbene Complexes: Recent Synthetic Strategies and Medicinal Applications.
    Nayak S; Gaonkar SL
    ChemMedChem; 2021 May; 16(9):1360-1390. PubMed ID: 33277791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
    Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M
    Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl
    Truong D; Sullivan MP; Tong KKH; Steel TR; Prause A; Lovett JH; Andersen JW; Jamieson SMF; Harris HH; Ott I; Weekley CM; Hummitzsch K; Söhnel T; Hanif M; Metzler-Nolte N; Goldstone DC; Hartinger CG
    Inorg Chem; 2020 Mar; 59(5):3281-3289. PubMed ID: 32073260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Medicinal Applications of Coinage-Metal (Cu and Ag) N-Heterocyclic Carbene Complexes.
    Marinelli M; Santini C; Pellei M
    Curr Top Med Chem; 2016; 16(26):2995-3017. PubMed ID: 27150368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell Lines.
    Curado N; Giménez N; Miachin K; Aliaga-Lavrijsen M; Cornejo MA; Jarzecki AA; Contel M
    ChemMedChem; 2019 Jun; 14(11):1086-1095. PubMed ID: 30924298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal/N-heterocyclic carbene complexes: opportunities for the development of anticancer metallodrugs.
    Cisnetti F; Gautier A
    Angew Chem Int Ed Engl; 2013 Nov; 52(46):11976-8. PubMed ID: 24115500
    [No Abstract]   [Full Text] [Related]  

  • 11. New insights in Au-NHCs complexes as anticancer agents.
    Porchia M; Pellei M; Marinelli M; Tisato F; Del Bello F; Santini C
    Eur J Med Chem; 2018 Feb; 146():709-746. PubMed ID: 29407992
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    A Patil S; P Hoagland A; A Patil S; Bugarin A
    Future Med Chem; 2020 Dec; 12(24):2239-2275. PubMed ID: 33228391
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands.
    Scattolin T; Caligiuri I; Mouawad N; El Boustani M; Demitri N; Rizzolio F; Visentin F
    Eur J Med Chem; 2019 Oct; 179():325-334. PubMed ID: 31255929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects.
    Schmidt C; Karge B; Misgeld R; Prokop A; Franke R; Brönstrup M; Ott I
    Chemistry; 2017 Feb; 23(8):1869-1880. PubMed ID: 27865002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal-N-heterocyclic carbene complexes as anti-tumor agents.
    Hu C; Li X; Wang W; Zhang R; Deng L
    Curr Med Chem; 2014 Apr; 21(10):1220-30. PubMed ID: 24350852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triazolyl-Functionalized N-Heterocyclic Carbene Half-Sandwich Compounds: Coordination Mode, Reactivity and in vitro Anticancer Activity.
    Tong KKH; Hanif M; Movassaghi S; Sullivan MP; Lovett JH; Hummitzsch K; Söhnel T; Jamieson SMF; Bhargava SK; Harris HH; Hartinger CG
    ChemMedChem; 2021 Oct; 16(19):3017-3026. PubMed ID: 34196118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel cis-[(NHC)
    Rehm T; Rothemund M; Muenzner JK; Noor A; Kempe R; Schobert R
    Dalton Trans; 2016 Oct; 45(39):15390-15398. PubMed ID: 27603959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward multifunctional anticancer therapeutics: post-synthetic carbonate functionalisation of asymmetric Au(i) bis-N-heterocyclic carbenes.
    Sen S; Perrin MW; Sedgwick AC; Dunsky EY; Lynch VM; He XP; Sessler JL; Arambula JF
    Chem Commun (Camb); 2020 Jul; 56(57):7877-7880. PubMed ID: 32520019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AgOC(CF(3))(3): an alternative and efficient reagent for preparing transition metal-NHC-carbene complexes.
    Maishal TK; Basset JM; Boualleg M; Copéret C; Veyre L; Thieuleux C
    Dalton Trans; 2009 Sep; (35):6956-9. PubMed ID: 20449136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct functionalisation of group 10 N-heterocyclic carbene complexes for diversity enhancement.
    Chardon E; Puleo GL; Dahm G; Guichard G; Bellemin-Laponnaz S
    Chem Commun (Camb); 2011 May; 47(20):5864-6. PubMed ID: 21503314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.